中文名称 | (S)-2-((R)-2-(2-((3,3-二丁基-7-(甲硫基)-1,1-二氧化-5-苯基-2,3,4,5-四氢苯并[f][1,2,5]硫二氮杂卓-8-基)氧基)乙酰胺)-2-(4-羟基苯基)乙酰胺基)丁酸 |
---|---|
英文名称 | Odevixibat (Synonyms: A4250) |
CAS号 | 501692-44-0 |
分子式 | C37H48N4O8S2 |
分子量 | 740.93 |
MDL | MFCD32710220 |
外观 | White to off-white powder |
储存条件 | -20°C, stored under nitrogen |
Odevixibat (A4250) is a selective and potent ASBT inhibitor that is taken orally. It has shown the ability to reduce cholestatic liver and bile duct injury in mouse models, positioning it as a potential treatment for primary biliary cirrhosis.
© 2020-2024 凯立德生物医药技术(上海)有限公司 版权所有
沪ICP备15046197号-3
沪公网安备31011502007856号
Designed by Kuanersoft